Global Vaccine Adjuvants Market to Reach US$ 2,639.3 Million by 2032, Propelled by the Rising Incidences of Infectious Diseases and Allergies

October 03, 2022 | Healthcare

The latest report by IMARC, titled “Vaccine Adjuvants Market Report by Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, and Others), Route of Administration (Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal, and Others), Diseases (Cancer, Infectious Diseases, and Others), Application (Research, Commercial), and Region 2024-2032”, finds that the global vaccine adjuvants market size reached US$ 996.5 Million in 2023. Vaccine adjuvants are compounds that improve the body’s immunogenic response against antigens. They increase the ability of the vaccines to induce long-term protection against infections. Presently, aluminum salts and MF59 are the only adjuvants found fit for human use. In recent years, the demand for vaccine adjuvants has escalated as they increase antibody titers, reduce required antigen doses, induce a rapid immune response and long-lasting memory, and enhance the immune response in the elderly and young children.

Global Vaccine Adjuvants Market Trends:

One of the primary factors driving the market is the rising incidences of infectious diseases and allergies, such as human immunodeficiency virus (HIV/AIDS), cancer, human papillomavirus (HPV), and tuberculosis. Additionally, the need for advanced treatment options for prevailing and emerging fatal diseases has increased the need to develop vaccines possessing long-lasting effects on immunization. Other than this, governments of numerous nations are taking initiatives for immunization and improvements in adjuvants for human consumption. They are also focusing on enhancing the healthcare infrastructure and increasing investments in research and development (R&D) of new therapeutics, which is creating a positive market outlook. Furthermore, with the sudden coronavirus (COVID-19) outburst, the demand for effective and safe vaccine adjuvants is constantly increasing. On account of these factors, IMARC Group expects the market value to reach US$ 2,639.3 Million by 2032, expanding at a CAGR of 11.1% during the forecast period (2024-2032).

Market Summary:

  • Based on the product type, the market has been divided into adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and others.
  • On the basis of the route of administration, the market has been segmented into oral, intramuscular, intranasal, subcutaneous, intradermal, and others.
  • Based on the diseases, the market has been categorized into cancer, infectious diseases, and others.
  • On the basis of the application, the market has been bifurcated into research and commercial.
  • Region-wise, the market has been classified into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Adjuvatis, Agenus Inc., Croda International Plc, CSL Limited, Dynavax Technologies, InvivoGen, Novavax Inc., OZ Biosciences, Phibro Animal Health Corporation, SEPPIC, SPI Pharma, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Product Type, Route of Administration, Diseases, Application, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Adjuvatis, Agenus Inc., Croda International Plc, CSL Limited, Dynavax Technologies, InvivoGen, Novavax Inc., OZ Biosciences, Phibro Animal Health Corporation, SEPPIC, SPI Pharma, etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Vaccine Adjuvants Market to Reach US$ 2,639.3 Million by 2032, Propelled by the Rising Incidences of Infectious Diseases and Allergies
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More